These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15272534)

  • 1. Immunoreactivity of hepatocyte paraffin 1 monoclonal antibody in cutaneous metastatic tumors.
    Kanitakis J; Chouvet B; Claudy A; Scoazec JY
    Am J Clin Pathol; 2004 Jul; 122(1):85-9. PubMed ID: 15272534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoreactivity for hepatocyte paraffin 1 antibody in hepatoid adenocarcinomas of the gastrointestinal tract.
    Maitra A; Murakata LA; Albores-Saavedra J
    Am J Clin Pathol; 2001 May; 115(5):689-94. PubMed ID: 11345832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of antihepatocyte clone OCH1E5 (Hep Par 1) in histological evaluation of liver tumors.
    Amarapurkar AD; Rege JD; Joshi AS; Vaiphei K; Amarapurkar DN
    Indian J Pathol Microbiol; 2006 Jul; 49(3):341-4. PubMed ID: 17001880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte paraffin 1 expression in human normal and neoplastic tissues: tissue microarray analysis on 3,940 tissue samples.
    Lugli A; Tornillo L; Mirlacher M; Bundi M; Sauter G; Terracciano LM
    Am J Clin Pathol; 2004 Nov; 122(5):721-7. PubMed ID: 15491968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte paraffin 1 antibody does not distinguish primary ovarian tumors with hepatoid differentiation from metastatic hepatocellular carcinoma.
    Pitman MB; Triratanachat S; Young RH; Oliva E
    Int J Gynecol Pathol; 2004 Jan; 23(1):58-64. PubMed ID: 14668552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The utility of hepatocyte paraffin 1 antibody in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma and metastatic carcinoma.
    Shiran MS; Isa MR; Sherina MS; Rampal L; Hairuszah I; Sabariah AR
    Malays J Pathol; 2006 Dec; 28(2):87-92. PubMed ID: 18376797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical evaluation of hepatoblastomas with use of the hepatocyte-specific marker, hepatocyte paraffin 1, and the polyclonal anti-carcinoembryonic antigen.
    Fasano M; Theise ND; Nalesnik M; Goswami S; Garcia de Davila MT; Finegold MJ; Greco MA
    Mod Pathol; 1998 Oct; 11(10):934-8. PubMed ID: 9796718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistological evaluation of single small hepatocellular carcinoma with negative staining of monoclonal antibody Hepatocyte Paraffin 1.
    Sugiki T; Yamamoto M; Aruga A; Takasaki K; Nakano M
    J Surg Oncol; 2004 Nov; 88(2):104-7. PubMed ID: 15499598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastatic hepatocellular carcinoma of skin diagnosed with hepatocyte paraffin 1 and a-fetoprotein immunostainings.
    Terada T; Sugiura M
    Int J Surg Pathol; 2010 Oct; 18(5):433-6. PubMed ID: 18499685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hep par-1: a novel immunohistochemical marker for differentiating hepatocellular carcinoma from metastatic carcinoma.
    Hanif R; Mansoor S
    J Coll Physicians Surg Pak; 2014 Mar; 24(3):186-9. PubMed ID: 24613115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein.
    Chu PG; Ishizawa S; Wu E; Weiss LM
    Am J Surg Pathol; 2002 Aug; 26(8):978-88. PubMed ID: 12170084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical characterization of canine hyperplastic hepatic lesions and hepatocellular and biliary neoplasms with monoclonal antibody hepatocyte paraffin 1 and a monoclonal antibody to cytokeratin 7.
    Ramos-Vara JA; Miller MA; Johnson GC
    Vet Pathol; 2001 Nov; 38(6):636-43. PubMed ID: 11732796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Podoplanin is a highly sensitive and specific marker to distinguish primary skin adnexal carcinomas from adenocarcinomas metastatic to skin.
    Liang H; Wu H; Giorgadze TA; Sariya D; Bellucci KS; Veerappan R; Liegl B; Acs G; Elenitsas R; Shukla S; Youngberg GA; Coogan PS; Pasha T; Zhang PJ; Xu X
    Am J Surg Pathol; 2007 Feb; 31(2):304-10. PubMed ID: 17255777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma.
    Lau SK; Prakash S; Geller SA; Alsabeh R
    Hum Pathol; 2002 Dec; 33(12):1175-81. PubMed ID: 12514785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoreactivity of Hep Par 1 in hepatic and extrahepatic tumors and its correlation with albumin in situ hybridization in hepatocellular carcinoma.
    Kakar S; Muir T; Murphy LM; Lloyd RV; Burgart LJ
    Am J Clin Pathol; 2003 Mar; 119(3):361-6. PubMed ID: 12645337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous metastasis of hepatocellular carcinoma diagnosed with hepatocyte paraffin (Hep Par 1) antibody immunohistochemistry.
    Kanitakis J; Causeret AS; Claudy A; Scoazec JY
    J Cutan Pathol; 2003 Nov; 30(10):637-40. PubMed ID: 14744089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
    Sheridan T; Herawi M; Epstein JI; Illei PB
    Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinoma metastatic to skin: diagnostic utility of antihuman hepatocyte antibody in combination with albumin in situ hybridization.
    Wood AJ; Lappinga PJ; Ahmed I
    J Cutan Pathol; 2009 Feb; 36(2):262-6. PubMed ID: 18727662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of monoclonal antibody HIK1083 specific for gastric O-glycan in differentiating cutaneous metastasis of gastric cancer from primary sweat gland carcinoma.
    Iijima M; Nakayama J; Nishizawa T; Ishida A; Ishii K; Ota H; Katsuyama T; Saida T
    Am J Dermatopathol; 2007 Oct; 29(5):452-6. PubMed ID: 17890913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of CD10 to pCEA, MOC-31, and hepatocyte for the distinction of malignant tumors in the liver.
    Morrison C; Marsh W; Frankel WL
    Mod Pathol; 2002 Dec; 15(12):1279-87. PubMed ID: 12481008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.